Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD)

ClinicalTrials.gov ID: NCT03712787

Public ClinicalTrials.gov record NCT03712787. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 1:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Extension Study of ABBV-8E12 in Early Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the long-term safety and tolerability of ABBV-8E12 in participants with early AD.

Study identification

NCT ID
NCT03712787
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie
Industry
Enrollment
364 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
57 Years to 88 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 21, 2019
Primary completion
Sep 29, 2021
Completion
Sep 29, 2021
Last update posted
Sep 21, 2022

2019 – 2021

United States locations

U.S. sites
32
U.S. states
20
U.S. cities
30
Facility City State ZIP Site status
Banner University of Arizona Medical Center Phoenix /ID# 203959 Phoenix Arizona 85006
Irvine Clinical Research /ID# 204000 Irvine California 92614
Ucsd /Id# 204001 La Jolla California 92037
University of California, San /ID# 204011 San Francisco California 94143-0633
Brain Matters Research /ID# 203957 Delray Beach Florida 33445
Neuropsychiatric Research Center of Southwest Florida /ID# 203956 Fort Myers Florida 33912
Mayo Clinic /ID# 203995 Jacksonville Florida 32224
Synexus Clinical Research US, Inc. /ID# 203992 Orlando Florida 32806-1044
University of South Florida /ID# 204009 Tampa Florida 33612
Synexus Clinical Research US, Inc /ID# 204010 The Villages Florida 32162-7116
Emory University / Emory Brain Health Center /ID# 203999 Atlanta Georgia 30329-2206
NeuroStudies.net, LLC /ID# 204004 Decatur Georgia 30030
Advocate Lutheran General Hospital /ID# 203993 Park Ridge Illinois 60068
Southern IL Univ School of Med /ID# 203952 Springfield Illinois 62702
Indiana University /ID# 203989 Indianapolis Indiana 46202
University of Kansas Medical Center - Alzheimer's Disease Center /ID# 203960 Fairway Kansas 66205
University of Kentucky Chandler Medical Center /ID# 203996 Lexington Kentucky 40536
Massachusetts General Hospital /ID# 203954 Boston Massachusetts 02114
Brigham and Women's Physicians /ID# 204003 Boston Massachusetts 02115
Hattiesburg Clinic /ID# 213435 Hattiesburg Mississippi 39401
Princeton Medical Institute /ID# 203953 Princeton New Jersey 08540
North Shore University Hospital /ID# 203994 New Hyde Park New York 11040
Duke Univ Med Ctr /ID# 203958 Durham North Carolina 27710
Oregon Health and Science University /ID# 203997 Portland Oregon 97239
Keystone Clinical Studies LLC /ID# 213183 Plymouth Meeting Pennsylvania 19462
Rhode Island Hospital /ID# 204005 Providence Rhode Island 02903
Vanderbilt Ingram Cancer Center /ID# 203951 Nashville Tennessee 37232-0021
Kerwin Research Center /ID# 203998 Dallas Texas 75231-4316
Houston Methodist Hospital /ID# 204002 Houston Texas 77030
McGovern Medical School /ID# 213312 Houston Texas 77054
University of Utah /ID# 203991 Salt Lake City Utah 84112-5500
Integrated Neurology Services /ID# 203990 Alexandria Virginia 22310

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03712787, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 21, 2022 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03712787 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →